| Date | Form | Description | Docs | XBRL | Pages |
| 11/22/17 | 8-K | Current report filing |
|
3 | |
| 11/17/17 | 8-K | Current report filing |
|
3 | |
| 11/17/17 | 8-K | Current report filing |
|
48 | |
| 11/17/17 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
45 | |
| 10/26/17 | EFFECT | Notice of Effectiveness |
|
1 | |
| 10/24/17 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 10/23/17 | UPLOAD | SEC-generated letter |
|
2 | |
| 10/23/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/16/17 | S-3 | Registration statement for specified transactions by certain issuers |
|
30 | |
| 10/03/17 | 8-K | Current report filing |
|
4 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...